Corporate
About ACI
Team
Scientific Advisory Board
Our Approach
ALPHA-1062
Alzheimer's Disease
Traumatic Brain Injury
ALPHA-0602
Amyotrophic Lateral Sclerosis
ALPHA-0702 and ALPHA-0802 (GEMs)
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
Contact
Menu
Corporate
About ACI
Team
Scientific Advisory Board
Our Approach
ALPHA-1062
Alzheimer's Disease
Traumatic Brain Injury
ALPHA-0602
Amyotrophic Lateral Sclerosis
ALPHA-0702 and ALPHA-0802 (GEMs)
Our Pipeline
Investors
Stock Info
News
Financials and Filings
Events & Presentations
Investor Relations Contact
Governance
Contact
Bringing Hope
to People Living with Neurodegenerative Diseases
Investor Presentation
Latest News Release
06.22.2022
Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease
Read More
Treatments
Alzheimers: ALPHA-1062
A New Approach
Read More
Quick Links
About ACI
ALPHA-0602
Team
Contact
Latest News
View All
06.22.2022
Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease
Read More
06.15.2022
Alpha Cognition Announces Successful Defense of European Patent Covering ALPHA-0602
Read More
View All
TSX-V: ACOG
15 min delay
Last
$0.52
Change
$0.02
Open
0.50
Vol
10,500
High
0.52
Low
0.50
Stock Information
